Molina Healthcare, Inc. (MOH) stock analysis
Close on Nov 11, 2026Market cap $10.92BP/E –Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak5 of 30 checks passed
Molina Healthcare passes 5 of the 30 checks behind our score; 10 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 2/6
- Past performance
- 0/6
- Financial health
- 2/6
- Dividend
- 0/6
What stands out
Revenue growing 10%+ a year
Revenue grew 12.4% a year over the last three fiscal years.
Guidance raised
Molina Healthcare raised its full year 2026 GAAP earnings outlook on Jul 22, 2026.
P/S below the industry
Molina Healthcare's price-to-sales of 0.25 is below the Accident and Health Insurance and Medical median of 0.80.
Debt falling against equity
Debt to equity fell from 101% five years ago to 90.8%.
What to watch
Return on equity under 15%
Return on equity was -1.2% over the last twelve months and averaged 24.9% over five years; we look for 15% on both.
High debt
Debt is 90.8% of shareholders' equity, above the 40% we consider low.
Earnings shrank over 5 years
Net income shrank 6.8% a year on average over the last five fiscal years.
EPS growing under 10% a year
Diluted EPS grew -13.0% a year over the last three fiscal years.
Valuation1/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S below the industry
Molina Healthcare's price-to-sales of 0.25 is below the Accident and Health Insurance and Medical median of 0.80.
P/B above the industry
Molina Healthcare's price-to-book of 2.63 is above the Accident and Health Insurance and Medical median of 2.31.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth2/6
Revenue growing 10%+ a year
Revenue grew 12.4% a year over the last three fiscal years.
EPS growing under 10% a year
Diluted EPS grew -13.0% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -105% over the last twelve months, against a 5-year average of -6.8% a year.
Growing slower than the industry
Revenue grew -0.9% over the last twelve months; the Accident and Health Insurance and Medical median is 6.8%.
Guidance raised
Molina Healthcare raised its full year 2026 GAAP earnings outlook on Jul 22, 2026.
Gross margin slipping
Gross margin was 12.6% over the last twelve months, against 13.9% a year earlier.
Past performance0/6
Return on equity under 15%
Return on equity was -1.2% over the last twelve months and averaged 24.9% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was -0.3%; for a bank or insurer, 1% or more is considered good.
Return on equity below the industry
Molina Healthcare's return on equity of -1.2% is below the Accident and Health Insurance and Medical median of 11.9%.
Earnings shrank over 5 years
Net income shrank 6.8% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was -0.1% over the last twelve months, against a 5-year average of 2.4%.
Net margin below the industry
Molina Healthcare's net margin of -0.1% is below the Accident and Health Insurance and Medical median of 2.0%.
Financial health2/6
High debt
Debt is 90.8% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 101% five years ago to 90.8%.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals 8.8% of total debt; we look for at least 20%.
Interest not well covered
Operating income covers interest expense 0.8 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 1.69 times current liabilities.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend0/6
No dividend
Molina Healthcare has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Molina Healthcare. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 20.3
- Accident and Health Insurance and Medical median 21.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $195.53M
- Value traded per 1% price move
- $75.78M
Downside
High risk
- Typical loss in a bad month
- 28.4%
- Volatility (annualized)
- 51%
- Sharpe ratio, 1 year
- 0.87
- Beta to the S&P 500 (5Y)
- 0.25
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +11.7% | +12.4% | +18.5% | +12.3% | |
| Gross profit | -4.6% | +7.4% | +19.1% | +14.5% | |
| Operating income | -54.2% | -12.7% | -6.2% | +7.3% | |
| Net income | -60.0% | -15.8% | -6.8% | +12.7% | |
| EPS, diluted | -56.3% | -13.0% | -4.5% | +13.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 3.2% | 33.2% | 11.0% | |
| Return on assets | 0.7% | 8.2% | 3.0% | |
| Current ratio | 1.31 | 1.59 | 1.69 | |
| Debt to equity | 0.88 | 1.01 | 0.93 | |
| Net debt to EBITDA | -3.00× | -1.80× | -0.49× | |
| Interest coverage | 3.0× | 10.6× | 4.1× | |
| Capex to revenue | 1.0% | 0.4% | 0.2% | |
| Diluted shares | 56M | 60M | 53M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Molina Healthcare generated $5.73B from operations and spent $2.98B on capital expenditure, dividends and share buybacks. 15% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 1.0% | 2.91× | 3.64× | 11.0% |
| FY2024 | 2.9% | 2.66× | 3.50× | 27.1% |
| FY2023 | 3.2% | 2.50× | 3.79× | 30.4% |
| FY2022 | 2.5% | 2.61× | 4.38× | 28.3% |
| FY2021 | 2.4% | 2.55× | 4.60× | 27.9% |
| FY2020 | 3.5% | 2.38× | 4.02× | 33.2% |
| FY2019 | 4.4% | 2.41× | 3.86× | 40.9% |
| FY2018 | 3.7% | 2.42× | 5.24× | 47.4% |
| FY2017 | -2.6% | 2.50× | 5.33× | -34.3% |
| FY2016 | 0.3% | 2.54× | 4.37× | 3.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$472.00M
- Cash generatingOperating cash flow above zero-$535.00M
- Return on assets improvedROA up on the prior year7.9% → 3.0%
- Earnings backed by cashOperating cash flow above net income-$535.00M vs $472.00M
- Less leverageLong-term debt to assets fell18.7% → 24.2%
- Better liquidityCurrent ratio rose1.62 → 1.69
- No dilutionShare count did not rise58M → 53M
- Gross margin improvedGross margin up on the prior year15.31% → 13.07%
- More efficientAsset turnover rose2.73 → 2.91
See a number that looks wrong?